Literature DB >> 25812763

Transmission of influenza A viruses.

Gabriele Neumann1, Yoshihiro Kawaoka2.   

Abstract

Influenza A viruses cause respiratory infections that range from asymptomatic to deadly in humans. Widespread outbreaks (pandemics) are attributable to 'novel' viruses that possess a viral hemagglutinin (HA) gene to which humans lack immunity. After a pandemic, these novel viruses form stable virus lineages in humans and circulate until they are replaced by other novel viruses. The factors and mechanisms that facilitate virus transmission among hosts and the establishment of novel lineages are not completely understood, but the HA and basic polymerase 2 (PB2) proteins are thought to play essential roles in these processes by enabling avian influenza viruses to infect mammals and replicate efficiently in their new host. Here, we summarize our current knowledge of the contributions of HA, PB2, and other viral components to virus transmission and the formation of new virus lineages.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gain-of-function; HA; Influenza virus; NA; PB2; Receptor-binding; Transmission; Virus lineage

Mesh:

Substances:

Year:  2015        PMID: 25812763      PMCID: PMC4424116          DOI: 10.1016/j.virol.2015.03.009

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  197 in total

1.  A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission.

Authors:  Terrence M Tumpey; Taronna R Maines; Neal Van Hoeven; Laurel Glaser; Alicia Solórzano; Claudia Pappas; Nancy J Cox; David E Swayne; Peter Palese; Jacqueline M Katz; Adolfo García-Sastre
Journal:  Science       Date:  2007-02-02       Impact factor: 47.728

2.  H6 influenza viruses pose a potential threat to human health.

Authors:  Guojun Wang; Guohua Deng; Jianzhong Shi; Weiyu Luo; Guoquan Zhang; Qianyi Zhang; Liling Liu; Yongping Jiang; Chengjun Li; Nongluk Sriwilaijaroen; Hiroaki Hiramatsu; Yasuo Suzuki; Yoshihiro Kawaoka; Hualan Chen
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.

Authors:  Kannan Tharakaraman; Akila Jayaraman; Rahul Raman; Karthik Viswanathan; Nathan W Stebbins; David Johnson; Zachary Shriver; V Sasisekharan; Ram Sasisekharan
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

4.  Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.

Authors:  M Hatta; P Gao; P Halfmann; Y Kawaoka
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

5.  H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet.

Authors:  Ying Zhang; Qianyi Zhang; Huihui Kong; Yongping Jiang; Yuwei Gao; Guohua Deng; Jianzhong Shi; Guobin Tian; Liling Liu; Jinxiong Liu; Yuntao Guan; Zhigao Bu; Hualan Chen
Journal:  Science       Date:  2013-05-02       Impact factor: 47.728

6.  Human infection with a novel avian-origin influenza A (H7N9) virus.

Authors:  Rongbao Gao; Bin Cao; Yunwen Hu; Zijian Feng; Dayan Wang; Wanfu Hu; Jian Chen; Zhijun Jie; Haibo Qiu; Ke Xu; Xuewei Xu; Hongzhou Lu; Wenfei Zhu; Zhancheng Gao; Nijuan Xiang; Yinzhong Shen; Zebao He; Yong Gu; Zhiyong Zhang; Yi Yang; Xiang Zhao; Lei Zhou; Xiaodan Li; Shumei Zou; Ye Zhang; Xiyan Li; Lei Yang; Junfeng Guo; Jie Dong; Qun Li; Libo Dong; Yun Zhu; Tian Bai; Shiwen Wang; Pei Hao; Weizhong Yang; Yanping Zhang; Jun Han; Hongjie Yu; Dexin Li; George F Gao; Guizhen Wu; Yu Wang; Zhenghong Yuan; Yuelong Shu
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

7.  A recommended numbering scheme for influenza A HA subtypes.

Authors:  David F Burke; Derek J Smith
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

8.  The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

Authors:  M Matrosovich; N Zhou; Y Kawaoka; R Webster
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003.

Authors:  Belinda Ostrowsky; Ada Huang; William Terry; Diane Anton; Barbara Brunagel; Lorraine Traynor; Syed Abid; Geraldine Johnson; Marilyn Kacica; Jacqueline Katz; Lindsay Edwards; Stephen Lindstrom; Alexander Klimov; Timothy M Uyeki
Journal:  Emerg Infect Dis       Date:  2012-07       Impact factor: 6.883

10.  One family cluster of avian influenza A(H7N9) virus infection in Shandong, China.

Authors:  Ti Liu; Zhenqiang Bi; Xianjun Wang; Zhong Li; Shujun Ding; Zhenwang Bi; Liansen Wang; Yaowen Pei; Shaoxia Song; Shengyang Zhang; Jianxing Wang; Dapeng Sun; Bo Pang; Lin Sun; Xiaolin Jiang; Jie Lei; Qun Yuan; Zengqiang Kou; Bin Yang; Yuelong Shu; Lei Yang; Xiyan Li; Kaishun Lu; Jun Liu; Tao Zhang; Aiqiang Xu
Journal:  BMC Infect Dis       Date:  2014-02-21       Impact factor: 3.090

View more
  60 in total

1.  Structural Basis for a Novel Interaction between the NS1 Protein Derived from the 1918 Influenza Virus and RIG-I.

Authors:  Alexander S Jureka; Alex B Kleinpeter; Gabriel Cornilescu; Claudia C Cornilescu; Chad M Petit
Journal:  Structure       Date:  2015-09-10       Impact factor: 5.006

2.  Mutations during the Adaptation of H9N2 Avian Influenza Virus to the Respiratory Epithelium of Pigs Enhance Sialic Acid Binding Activity and Virulence in Mice.

Authors:  W Yang; D Punyadarsaniya; R L O Lambertz; D C C Lee; C H Liang; D Höper; S R Leist; A Hernández-Cáceres; J Stech; M Beer; C Y Wu; C H Wong; K Schughart; F Meng; G Herrler
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

3.  Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry.

Authors:  Maria I Solano; Adrian R Woolfitt; Tracie L Williams; Carrie L Pierce; Larisa V Gubareva; Vasiliy Mishin; John R Barr
Journal:  Anal Chem       Date:  2017-02-21       Impact factor: 6.986

Review 4.  Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy.

Authors:  Santiago Di Lella; Andreas Herrmann; Caroline M Mair
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

5.  Influenza A Virus Coinfection through Transmission Can Support High Levels of Reassortment.

Authors:  Hui Tao; Lian Li; Maria C White; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

6.  Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.

Authors:  Xiangjie Sun; Joanna A Pulit-Penaloza; Jessica A Belser; Claudia Pappas; Melissa B Pearce; Nicole Brock; Hui Zeng; Hannah M Creager; Natosha Zanders; Yunho Jang; Terrence M Tumpey; C Todd Davis; Taronna R Maines
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

7.  Structural and Molecular Characterization of the Hemagglutinin from the Fifth-Epidemic-Wave A(H7N9) Influenza Viruses.

Authors:  Hua Yang; Paul J Carney; Jessie C Chang; Zhu Guo; James Stevens
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

8.  Influenza Hemagglutinin Head Domain Mimicry by Rational Design.

Authors:  V Vamsee Aditya Mallajosyula; Shiv Swaroop; Raghavan Varadarajan
Journal:  Protein J       Date:  2020-10-17       Impact factor: 2.371

9.  NS1 is the fluid for "flu-transmission".

Authors:  Tokiko Watanabe; Masaki Imai; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

10.  Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface.

Authors:  Seth J Zost; Jinhui Dong; Iuliia M Gilchuk; Pavlo Gilchuk; Natalie J Thornburg; Sandhya Bangaru; Nurgun Kose; Jessica A Finn; Robin Bombardi; Cinque Soto; Elaine C Chen; Rachel S Nargi; Rachel E Sutton; Ryan P Irving; Naveenchandra Suryadevara; Jonna B Westover; Robert H Carnahan; Hannah L Turner; Sheng Li; Andrew B Ward; James E Crowe
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.